Results 1-7 of 7 (Search time: 0.001 seconds).
|2017-08||Safety of resuming biologic DMARDs in patients who develop tuberculosis after anti-TNF treatment||배상철|
|2017-08||Diagnostic accuracy of anti-Sa and anti-RA33 antibodies in rheumatoid arthritis: a meta-analysis||배상철|
|2017-10||Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis||배상철|
|2017-10||Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis||배상철|
|2017-12||The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs||배상철|
|2017-06||Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab||배상철|
|2017-06||Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis||배상철|